Supreme Court decision brings concern over mental health impacts of conversion therapy.

  • AFSP voices concern over Supreme Court's ruling on conversion therapy.
  • The decision may impact mental health among LGBTQ+ individuals.
  • Critiques of conversion therapy underscore its potential harm.

The American Foundation for Suicide Prevention (AFSP) has expressed strong disapproval of the recent Supreme Court ruling regarding conversion therapy. This decision has raised significant concerns over the harmful effects such practices can have on the mental health of LGBTQ+ individuals. Conversion therapy, which aims to change a person's sexual orientation or gender identity, has been widely criticized by mental health professionals as ineffective and damaging.

AFSP's statement highlights the potential risks associated with conversion therapy, including increased rates of depression, anxiety, and suicidal behavior in those subjected to these practices. The organization urges lawmakers to prioritize mental health care and discourage any measures that could allow for the continued use of conversion therapy. This ruling aligns against a growing trend where many states have enacted bans on such therapies, reflecting a shift towards better mental health support for the LGBTQ+ community.

Additionally, AFSP emphasizes the need to protect vulnerable populations by promoting positive and affirming mental health care. They argue that safeguarding mental wellness is crucial, especially in light of evidence demonstrating the harms of conversion therapy. The Supreme Court's ruling and its implications for mental health policy remain a contentious topic as advocates push for legislative measures that create a supportive environment for all.

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

BD Helps Scientists Advance Immunology and Cancer Research with AI-Powered Insights and Automation

Innovative automation enhances cancer research and immunological studies. AI-powered tools improve research…

HelpMeSee Unveils Next-Generation MSICS Training System at SAFO

New training system aims to improve global solutions for blindness. HelpMeSee launches…

Pharmacelera Raises $6M to Expand in US and Enhance Drug Discovery Platform

Funding will support growth and technological advancements in drug discovery. Pharmacelera has…

WuXi Biologics and Vertex Enter Research Agreement for T-Cell Engager

Collaboration focuses on advancing T-cell engager therapies for cancer treatment WuXi Biologics…